photo free
Home Images Vectors Videos

Stock image Dpp 4

stock image Sitagliptin - medical concept

Sitagliptin - Medical Concept

Image, 2.72MB, 5000 × 3182 jpg
stock vector Linagliptin, C25H28N8O2 molecule. It is DPP-4 inhibitor, used for the treatment of type II diabetes. Structural chemical formula on the dark blue background. Vector illustration

Linagliptin, C25H28N8O2 Molecule. It Is DPP-4 Inhibitor, Used For The Treatment Of Type II Diabetes. Structural Chemical Formula On The Dark Blue Background. Vector Illustration

Vector, 0.32MB, 5855 × 4270 eps
stock image Alogliptin molecular structure isolated on white

Alogliptin Molecular Structure Isolated On White

Image, 0.49MB, 7000 × 3038 jpg
stock image Linagliptin or Tradjenta is a medication used to treat diabetes mellitus type 2. 3d illustration

Linagliptin Or Tradjenta Is A Medication Used To Treat Diabetes Mellitus Type 2. 3d Illustration

Image, 0.85MB, 7000 × 3638 jpg
stock image Prague,Czech Republic-August 10 2024: JENTADUETO box of tablets with LINAGLIPTIN and METFORMIN active substances, used for treatment of type 2 diabetes, blood sugar control.

Prague,Czech Republic-August 10 2024: JENTADUETO Box Of Tablets With LINAGLIPTIN And METFORMIN Active Substances, Used For Treatment Of Type 2 Diabetes, Blood Sugar Control.

Image, 2.08MB, 4032 × 3024 jpg
stock image Prague,Czech Republic-August 7 2024: JANUVIA box of medication with SITAGLIPTIN active substance by MERCK,used for treatment of type 2 diabetes

Prague,Czech Republic-August 7 2024: JANUVIA Box Of Medication With SITAGLIPTIN Active Substance By MERCK,used For Treatment Of Type 2 Diabetes

Image, 2.26MB, 3024 × 4032 jpg
stock image Prague, Czech Republic - July 10 2024: JENTADUETO box of medication with LINAGLIPTIN and METFORMIN active substances by BOEHRINGER INGELHEIM, used for treatment of type 2 diabetes and blood sugar control.

Prague, Czech Republic - July 10 2024: JENTADUETO Box Of Medication With LINAGLIPTIN And METFORMIN Active Substances By BOEHRINGER INGELHEIM, Used For Treatment Of Type 2 Diabetes And Blood Sugar Control.

Image, 2.21MB, 3024 × 4032 jpg
stock image Prague,Czech Republic-August 10 2024: VIPIDOMET box of medication with ALOGLIPTIN and METFORMIN active substances by TAKEDA,used for treatment of type 2 diabetes.

Prague,Czech Republic-August 10 2024: VIPIDOMET Box Of Medication With ALOGLIPTIN And METFORMIN Active Substances By TAKEDA,used For Treatment Of Type 2 Diabetes.

Image, 2.28MB, 4032 × 3024 jpg
stock image Prague,Czech Republic-August 7 2024: JANUVIA box of medication with SITAGLIPTIN active substance by MERCK,used for treatment of type 2 diabetes

Prague,Czech Republic-August 7 2024: JANUVIA Box Of Medication With SITAGLIPTIN Active Substance By MERCK,used For Treatment Of Type 2 Diabetes

Image, 2.44MB, 4032 × 3024 jpg
stock image Prague,Czech Republic-August 7 2024: JANUVIA box of medication with SITAGLIPTIN active substance by MERCK,used for treatment of type 2 diabetes

Prague,Czech Republic-August 7 2024: JANUVIA Box Of Medication With SITAGLIPTIN Active Substance By MERCK,used For Treatment Of Type 2 Diabetes

Image, 2.21MB, 4032 × 3024 jpg
stock image Alogliptin molecular structure isolated on grey

Alogliptin Molecular Structure Isolated On Grey

Image, 0.48MB, 7000 × 3038 jpg
stock image Prague,Czech Republic-August 10 2024: JENTADUETO box of tablets with LINAGLIPTIN and METFORMIN active substances, used for treatment of type 2 diabetes, blood sugar control.

Prague,Czech Republic-August 10 2024: JENTADUETO Box Of Tablets With LINAGLIPTIN And METFORMIN Active Substances, Used For Treatment Of Type 2 Diabetes, Blood Sugar Control.

Image, 2.17MB, 3024 × 4032 jpg
stock image Prague, Czech Republic - July 10 2024: JENTADUETO box of medication with LINAGLIPTIN and METFORMIN active substances by BOEHRINGER INGELHEIM, used for treatment of type 2 diabetes and blood sugar control.

Prague, Czech Republic - July 10 2024: JENTADUETO Box Of Medication With LINAGLIPTIN And METFORMIN Active Substances By BOEHRINGER INGELHEIM, Used For Treatment Of Type 2 Diabetes And Blood Sugar Control.

Image, 2.23MB, 4032 × 3024 jpg
stock image Prague,Czech Republic-August 7 2024: JANUVIA box of medication with SITAGLIPTIN active substance by MERCK,used for treatment of type 2 diabetes

Prague,Czech Republic-August 7 2024: JANUVIA Box Of Medication With SITAGLIPTIN Active Substance By MERCK,used For Treatment Of Type 2 Diabetes

Image, 2.44MB, 3024 × 4032 jpg
stock image Prague,Czech Republic-August 7 2024: JANUVIA box of medication with SITAGLIPTIN active substance by MERCK,used for treatment of type 2 diabetes

Prague,Czech Republic-August 7 2024: JANUVIA Box Of Medication With SITAGLIPTIN Active Substance By MERCK,used For Treatment Of Type 2 Diabetes

Image, 2.67MB, 3024 × 4032 jpg
stock image Prague,Czech Republic-August 10 2024: VIPIDOMET box of medication with ALOGLIPTIN and METFORMIN active substances by TAKEDA,used for treatment of type 2 diabetes.

Prague,Czech Republic-August 10 2024: VIPIDOMET Box Of Medication With ALOGLIPTIN And METFORMIN Active Substances By TAKEDA,used For Treatment Of Type 2 Diabetes.

Image, 2.53MB, 4032 × 3024 jpg
stock image Prague,Czech Republic-August 10 2024: VIPIDOMET box of medication with ALOGLIPTIN and METFORMIN active substances by TAKEDA,used for treatment of type 2 diabetes.

Prague,Czech Republic-August 10 2024: VIPIDOMET Box Of Medication With ALOGLIPTIN And METFORMIN Active Substances By TAKEDA,used For Treatment Of Type 2 Diabetes.

Image, 2.36MB, 4032 × 3024 jpg
stock image Prague,Czech Republic-August 7 2024: JANUVIA box of medication with SITAGLIPTIN active substance by MERCK,used for treatment of type 2 diabetes

Prague,Czech Republic-August 7 2024: JANUVIA Box Of Medication With SITAGLIPTIN Active Substance By MERCK,used For Treatment Of Type 2 Diabetes

Image, 2.5MB, 4032 × 3024 jpg
stock image Prague,Czech Republic-August 7 2024: JANUVIA box of medication with SITAGLIPTIN active substance by MERCK,used for treatment of type 2 diabetes

Prague,Czech Republic-August 7 2024: JANUVIA Box Of Medication With SITAGLIPTIN Active Substance By MERCK,used For Treatment Of Type 2 Diabetes

Image, 2.39MB, 3024 × 4032 jpg
stock image Prague,Czech Republic-August 7 2024: JANUVIA box of medication with SITAGLIPTIN active substance by MERCK,used for treatment of type 2 diabetes

Prague,Czech Republic-August 7 2024: JANUVIA Box Of Medication With SITAGLIPTIN Active Substance By MERCK,used For Treatment Of Type 2 Diabetes

Image, 2.42MB, 3024 × 4032 jpg
stock image Prague, Czech Republic - July 10 2024: JENTADUETO box of medication with LINAGLIPTIN and METFORMIN active substances by BOEHRINGER INGELHEIM, used for treatment of type 2 diabetes and blood sugar control.

Prague, Czech Republic - July 10 2024: JENTADUETO Box Of Medication With LINAGLIPTIN And METFORMIN Active Substances By BOEHRINGER INGELHEIM, Used For Treatment Of Type 2 Diabetes And Blood Sugar Control.

Image, 2.19MB, 3024 × 4032 jpg
stock image Prague,Czech Republic-August 10 2024: VIPIDOMET box of medication with ALOGLIPTIN and METFORMIN active substances by TAKEDA,used for treatment of type 2 diabetes.

Prague,Czech Republic-August 10 2024: VIPIDOMET Box Of Medication With ALOGLIPTIN And METFORMIN Active Substances By TAKEDA,used For Treatment Of Type 2 Diabetes.

Image, 2.39MB, 4032 × 3024 jpg
stock image Prague, Czech Republic - July 10 2024: JENTADUETO box of medication with LINAGLIPTIN and METFORMIN active substances by BOEHRINGER INGELHEIM, used for treatment of type 2 diabetes and blood sugar control.

Prague, Czech Republic - July 10 2024: JENTADUETO Box Of Medication With LINAGLIPTIN And METFORMIN Active Substances By BOEHRINGER INGELHEIM, Used For Treatment Of Type 2 Diabetes And Blood Sugar Control.

Image, 2.22MB, 4032 × 3024 jpg
stock image Prague,Czech Republic-August 10 2024: JENTADUETO box of tablets with LINAGLIPTIN and METFORMIN active substances, used for treatment of type 2 diabetes, blood sugar control.

Prague,Czech Republic-August 10 2024: JENTADUETO Box Of Tablets With LINAGLIPTIN And METFORMIN Active Substances, Used For Treatment Of Type 2 Diabetes, Blood Sugar Control.

Image, 2.18MB, 3024 × 4032 jpg
stock image Prague, Czech Republic - July 10 2024: JENTADUETO box of medication with LINAGLIPTIN and METFORMIN active substances by BOEHRINGER INGELHEIM, used for treatment of type 2 diabetes and blood sugar control.

Prague, Czech Republic - July 10 2024: JENTADUETO Box Of Medication With LINAGLIPTIN And METFORMIN Active Substances By BOEHRINGER INGELHEIM, Used For Treatment Of Type 2 Diabetes And Blood Sugar Control.

Image, 2.01MB, 4032 × 3024 jpg
stock image Prague,Czech Republic-August 10 2024: VIPIDOMET box of medication with ALOGLIPTIN and METFORMIN active substances by TAKEDA,used for treatment of type 2 diabetes.

Prague,Czech Republic-August 10 2024: VIPIDOMET Box Of Medication With ALOGLIPTIN And METFORMIN Active Substances By TAKEDA,used For Treatment Of Type 2 Diabetes.

Image, 2.4MB, 4032 × 3024 jpg
Page 1 >> Next